Update your location to show providers, locations, and services closest to you.
Dr. McFarland is an active member of the Center for Translational Research in Neurodegenerative Disease (CTRND) which aims to bring the bench closer to the bedside. His research focuses on understanding the pathological mechanisms of Parkinson disease and related disorders, and in particular the role of alpha-synuclein in cell toxicity and neurodegeneration. His current studies utilize both cellular and preclinical models to study genes and molecules that may affect brain pathology. A primary goal of his research is to identify and to develop potential novel therapeutics for Parkinson disease and related disorders. His research extends also to the clinic where he is actively involved in multiple clinical trials for atypical Parkinson disorders and Huntington disease.
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America.…
86 publications
2024
JAMA
PubMed • Publisher's site2024
Movement disorders clinical practice
PubMed • Publisher's site2023
npj Parkinson's Disease
PubMed • Publisher's site2023
Current opinion in neurology
PubMed • Publisher's site2022
NeuroImage. Clinical
PubMed • Publisher's site